Doxazosin mesilate 4.8 mg (=doxazosin 4 mg) - 検索結果

idt australia ltd - doxazosin mesilate, quantity: 9.704 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; indigo carmine aluminium lake; pregelatinised maize starch; iron oxide yellow; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

doxazosin mesilate tablets 4 mg

idt australia ltd - doxazosin mesilate, quantity: 4.852 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; iron oxide red; microcrystalline cellulose; iron oxide yellow; pregelatinised maize starch; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

doxazosin mesilate tablets 2 mg

idt australia ltd - doxazosin mesilate, quantity: 2.426 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; iron oxide yellow - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

doxazosin mesilate tablets 1 mg

idt australia ltd - doxazosin mesilate, quantity: 1.213 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors